News

Win a $5,000 Grays Harbor getaway to Seabrook, Westport, and Ocean Shores! Plus, score weekly tickets to Silverwood Theme Park. Enter now!
Evening's Best Northwest Escapes 2025 starts nominations on April 21, offering a grand prize valued at $5,000.
Business Insider24d
Arvinas presents first-in-human data from ARV-102 trial
Arvinas (ARVN) presented data from the first-in-human clinical trial of ARV-102, the Company’s investigational PROteolysis TArgeting Chimera leucine-rich repeat kinase 2 degrader. In the trial ...
Yahoo Finance7d
Arvinas to Present Preclinical Data for PROTAC BCL6 Degrader, ARV-393, at 2025 American Association for Cancer Research® (AACR) Annual Meeting
The poster highlights the potential for ARV-393 to be combined with various standard of care lymphoma treatments. ARV-393 is Arvinas’ investigational PROteolysis TArgeting Chimera (PROTAC ...
Nasdaq7d
Arvinas, Inc. to Present Preclinical Data for ARV-393 at AACR Annual Meeting 2025
Arvinas, Inc., a biotechnology company focused on targeted protein degradation therapies, announced that new preclinical data for its investigational drug ARV-393 will be presented at the upcoming ...